Jianhua Xia

Introduction

Jianhua Xia is a prominent inventor based in Shanghai, China, known for his contributions to the field of pharmaceuticals. With a total of five patents to his name, he has made significant advancements, particularly in the area of nucleoprotein inhibitors and modified compounds.

Latest Patents

Among Jianhua Xia's latest inventions is a patent for a 2,3-dihydro-1H-pyrrolizine-7-formamide derivative. This application details its use as a nucleoprotein inhibitor, specifically targeting the preparation of drugs aimed at treating hepatitis B virus (HBV) related diseases. The compound described in this patent, represented by formula (II), includes isomers or pharmaceutically acceptable salts.

Additionally, he has developed a patent for a salt and crystal form of a modified andrographolide compound, along with its preparation method and pharmaceutical applications. This invention showcases his dedication to enhancing drug efficacy through innovative formulations.

Career Highlights

Throughout his career, Jianhua Xia has worked with several reputable companies, including Medshine Discovery Inc. and Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd. His work in these organizations has allowed him to apply his inventive skills in real-world applications, contributing to the pharmaceutical industry's progress.

Collaborations

Jianhua Xia has collaborated with notable colleagues such as Haiying He and Zhigan Jiang. These partnerships reflect his ability to work effectively within teams in the research and development of groundbreaking pharmaceutical innovations.

Conclusion

Jianhua Xia is a distinguished inventor whose work has the potential to significantly impact the treatment of various diseases. His innovative patents and collaborative experience underscore his status as a key figure in the pharmaceutical field. As he continues to develop new solutions, his contributions will play a vital role in addressing critical health challenges.